Mkts

PAVmed Inc.

NASDAQ: PAVM
$2.41-0.01 (-0.62%)
As of Oct 16, 9:30 AM ET

Key statistics

Day range
2.392.50
52-week range
2.2228.44
Today
Open2.42
Previous close2.41
Volume12.6K
Valuation
Market cap19.27M
P/E ratio—
EPS (TTM)-9.80
Income & risk
Dividend / yield—
Beta0.88
Avg volume10.6K
Discussion

PAVM News

Stories mentioning PAVM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue22.0052.005.006.008.0010.00996.00979.00
Cost of Goods Sold97.0086.0055.0041.0036.0049.001,3811,666
Gross Profit(75.00)(34.00)(50.00)(35.00)(28.00)(39.00)(385.00)(687.00)
Operating Expenses
Research & Development1,3881,8271,088790.00787.00808.001,5421,641
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(8,035)(6,801)(4,844)(4,715)(5,446)(5,189)(11,578)(13,684)
Interest Income19.008.00
Interest Expense26.0026.00
Other Expense(40.00)0.00
Pretax Income(1,064)(2,757)(6,011)(12,324)18,6231,14260,711(14,914)
Tax Provision0.000.00
Net Income (Loss)(60.00)(1,263)(5,383)(11,921)18,9681,43164,399(10,827)
Earnings Per Share (Basic)(4.42)(1.89)(0.29)(0.74)38.264.446.43(1.19)
Earnings Per Share (Diluted)(4.42)(1.89)(0.29)(0.74)10.100.661.44(1.19)
Weighted Average Shares Outstanding (Basic)1,581670.0021,55518,085463.00322.0010,0059,153
Weighted Average Shares Outstanding (Diluted)1,581670.0021,55518,0851,7472,17344,4769,153

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PAVM

PAVmed Inc. (NASDAQ: PAVM) is a stock listed on the Nasdaq Stock Market under the ticker symbol PAVM. It last traded at $2.41 (Oct 16, 2026, 9:30 AM ET), down 0.6% on the day. That gives PAVmed a market capitalisation of $19.3M.

Over the past 52 weeks PAVM has traded between $2.22 and $28.44.

Revenue for the quarter ended Mar 31, 2026 was $22.0K; a net loss of $60.0K. Revenue was up 175% from $8.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$22.0K-$60.0K-272.7%
Dec 31, 2025$52.0K-$1.3M-2428.8%
Sep 30, 2025$5.0K-$5.4M-107660.0%
Jun 30, 2025$6.0K-$11.9M-198683.3%

From PAVmed’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…